Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice.

Christou-Kent M, Kherraf ZE, Amiri-Yekta A, Le Blévec E, Karaouzène T, Conne B, Escoffier J, Assou S, Guttin A, Lambert E, Martinez G, Boguenet M, Fourati Ben Mustapha S, Cedrin Durnerin I, Halouani L, Marrakchi O, Makni M, Latrous H, Kharouf M, Coutton C, Thierry-Mieg N, Nef S, Bottari SP, Zouari R, Issartel JP, Ray PF, Arnoult C.

EMBO Mol Med. 2018 Apr 16. pii: e8515. doi: 10.15252/emmm.201708515. [Epub ahead of print]

2.

Mutations in CFAP43 and CFAP44 cause male infertility and flagellum defects in Trypanosoma and human.

Coutton C, Vargas AS, Amiri-Yekta A, Kherraf ZE, Ben Mustapha SF, Le Tanno P, Wambergue-Legrand C, Karaouzène T, Martinez G, Crouzy S, Daneshipour A, Hosseini SH, Mitchell V, Halouani L, Marrakchi O, Makni M, Latrous H, Kharouf M, Deleuze JF, Boland A, Hennebicq S, Satre V, Jouk PS, Thierry-Mieg N, Conne B, Dacheux D, Landrein N, Schmitt A, Stouvenel L, Lorès P, El Khouri E, Bottari SP, Fauré J, Wolf JP, Pernet-Gallay K, Escoffier J, Gourabi H, Robinson DR, Nef S, Dulioust E, Zouari R, Bonhivers M, Touré A, Arnoult C, Ray PF.

Nat Commun. 2018 Feb 15;9(1):686. doi: 10.1038/s41467-017-02792-7.

3.

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2018 Apr;14:694-696. doi: 10.1016/j.redox.2017.10.001. Epub 2017 Oct 26. No abstract available.

4.

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats.

Steven S, Oelze M, Hanf A, Kröller-Schön S, Kashani F, Roohani S, Welschof P, Kopp M, Gödtel-Armbrust U, Xia N, Li H, Schulz E, Lackner KJ, Wojnowski L, Bottari SP, Wenzel P, Mayoux E, Münzel T, Daiber A.

Redox Biol. 2017 Oct;13:370-385. doi: 10.1016/j.redox.2017.06.009. Epub 2017 Jun 22.

5.

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A.

Redox Biol. 2017 Oct;13:94-162. doi: 10.1016/j.redox.2017.05.007. Epub 2017 May 18. Review. Erratum in: Redox Biol. 2018 Apr;14 :694-696.

6.

SPINK2 deficiency causes infertility by inducing sperm defects in heterozygotes and azoospermia in homozygotes.

Kherraf ZE, Christou-Kent M, Karaouzene T, Amiri-Yekta A, Martinez G, Vargas AS, Lambert E, Borel C, Dorphin B, Aknin-Seifer I, Mitchell MJ, Metzler-Guillemain C, Escoffier J, Nef S, Grepillat M, Thierry-Mieg N, Satre V, Bailly M, Boitrelle F, Pernet-Gallay K, Hennebicq S, Fauré J, Bottari SP, Coutton C, Ray PF, Arnoult C.

EMBO Mol Med. 2017 Aug;9(8):1132-1149. doi: 10.15252/emmm.201607461.

7.

Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches.

Cipak Gasparovic A, Zarkovic N, Zarkovic K, Semen K, Kaminskyy D, Yelisyeyeva O, Bottari SP.

Br J Pharmacol. 2017 Jun;174(12):1771-1783. doi: 10.1111/bph.13673. Epub 2017 Mar 6. Review.

PMID:
27864827
8.

Protein tyrosine nitration: a signaling mechanism conserved from yeast to man.

Bottari SP.

Proteomics. 2015 Jan;15(2-3):185-7. doi: 10.1002/pmic.201400592.

PMID:
25529898
9.

The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.

Oelze M, Kröller-Schön S, Welschof P, Jansen T, Hausding M, Mikhed Y, Stamm P, Mader M, Zinßius E, Agdauletova S, Gottschlich A, Steven S, Schulz E, Bottari SP, Mayoux E, Münzel T, Daiber A.

PLoS One. 2014 Nov 17;9(11):e112394. doi: 10.1371/journal.pone.0112394. eCollection 2014.

10.

Monitoring metabolic responses of single mitochondria within poly(dimethylsiloxane) wells: study of their endogenous reduced nicotinamide adenine dinucleotide evolution.

Suraniti E, Vajrala VS, Goudeau B, Bottari SP, Rigoulet M, Devin A, Sojic N, Arbault S.

Anal Chem. 2013 May 21;85(10):5146-52. doi: 10.1021/ac400494e. Epub 2013 May 7.

PMID:
23600852
11.

Early transient hypoglycemia is associated with increased albumin nitration in the preterm infant.

Wayenberg JL, Cavedon C, Ghaddhab C, Lefèvre N, Bottari SP.

Neonatology. 2011;100(4):387-97. doi: 10.1159/000326936. Epub 2011 Jul 27.

PMID:
21791930
12.

Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.

Csibi A, Communi D, Müller N, Bottari SP.

PLoS One. 2010 Apr 7;5(4):e10070. doi: 10.1371/journal.pone.0010070.

13.

Nitrated plasma albumin as a marker of nitrative stress and neonatal encephalopathy in perinatal asphyxia.

Wayenberg JL, Ransy V, Vermeylen D, Damis E, Bottari SP.

Free Radic Biol Med. 2009 Oct 1;47(7):975-82. doi: 10.1016/j.freeradbiomed.2009.07.003. Epub 2009 Jul 8.

PMID:
19591921
14.

Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells.

Pinzar E, Wang T, Garrido MR, Xu W, Levy P, Bottari SP.

FEBS Lett. 2005 Sep 12;579(22):5100-4.

15.

Effect of consumption of food cooked in aluminium or stainless-steel pots on Bangladeshi children with calcium-deficient rickets: an eight month trial.

Cimma JP, Arnaud J, Labarere J, Guillard O, Nugues F, Marrauld A, Durand C, Farvacque JM, Bottari SP, Haque S.

J Trace Elem Med Biol. 2004;17(4):249-53.

PMID:
15139387
16.

Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.

Warnecke C, Willich T, Holzmeister J, Bottari SP, Fleck E, Regitz-Zagrosek V.

Biochem J. 1999 May 15;340 ( Pt 1):17-24.

17.

Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical tumorigenesis.

Chabre O, Liakos P, Vivier J, Chaffanjon P, Labat-Moleur F, Martinie M, Bottari SP, Bachelot I, Chambaz EM, Defaye G, Feige JJ.

J Clin Endocrinol Metab. 1998 Sep;83(9):3134-43.

PMID:
9745416
18.

Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction.

Steckelings UM, Bottari SP, Stoll M, Wagner J, Unger T.

J Mol Med (Berl). 1998 Mar;76(3-4):202-7.

PMID:
9535553
19.

ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells.

Liakos P, Bourmeyster N, Defaye G, Chambaz EM, Bottari SP.

Am J Physiol. 1997 Oct;273(4 Pt 1):C1324-34.

PMID:
9357777
20.

The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells.

Meffert S, Stoll M, Steckelings UM, Bottari SP, Unger T.

Mol Cell Endocrinol. 1996 Aug 30;122(1):59-67.

PMID:
8898348
21.

Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.

Bolla M, Rostaing-Puissant B, Bottari SP, Chedin M, Marron-Charriere J, Colonna M, Berland E, Chambaz E.

Breast Cancer Res Treat. 1996;39(3):327-34.

PMID:
8877013
23.

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T.

J Clin Invest. 1995 Feb;95(2):651-7.

24.

Stimulation of cortisol production through angiotensin AT2 receptors in bovine fasciculata cells.

Defaye G, Lecomte S, Chambaz EM, Bottari SP.

Endocr Res. 1995 Feb-May;21(1-2):183-7.

PMID:
7588379
25.

A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells.

Buisson B, Laflamme L, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD.

J Biol Chem. 1995 Jan 27;270(4):1670-4.

26.

Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism.

Brechler V, Reichlin S, De Gasparo M, Bottari SP.

Receptors Channels. 1994;2(2):89-98.

PMID:
7953293
27.

Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation?

Brechler V, Levens NR, De Gasparo M, Bottari SP.

Receptors Channels. 1994;2(2):79-87.

PMID:
7525002
28.

Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.

Bottari SP, de Gasparo M, Steckelings UM, Levens NR.

Front Neuroendocrinol. 1993 Apr;14(2):123-71. Review.

PMID:
8486206
29.

Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells.

Brechler V, Jones PW, Levens NR, de Gasparo M, Bottari SP.

Regul Pept. 1993 Mar 19;44(2):207-13.

PMID:
8385791
30.
31.

The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells.

Buisson B, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD.

FEBS Lett. 1992 Sep 7;309(2):161-4.

32.

Angiotensin receptor subtypes in the brain.

Steckelings UM, Bottari SP, Unger T.

Trends Pharmacol Sci. 1992 Sep;13(9):365-8. Review.

PMID:
1529481
33.

Characterization and distribution of angiotensin II binding sites in fetal and neonatal astrocytes from different rat brain regions.

Bottari SP, Obermüller N, Bogdal Y, Zahs KR, Deschepper CF.

Brain Res. 1992 Jul 10;585(1-2):372-6.

PMID:
1511322
34.

Brain angiotensin: receptors, actions and possible role in hypertension.

Steckelings UM, Obermüller N, Bottari SP, Qadri F, Veltmar A, Unger T.

Pharmacol Toxicol. 1992 Jun;70(6 Pt 2):S23-7. Review. No abstract available.

PMID:
1508845
35.

The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase.

Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, de Gasparo M.

Biochem Biophys Res Commun. 1992 Feb 28;183(1):206-11.

PMID:
1347447
36.

Radioiodinated CGP 42112A: a novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors.

Whitebread SE, Taylor V, Bottari SP, Kamber B, de Gasparo M.

Biochem Biophys Res Commun. 1991 Dec 31;181(3):1365-71.

PMID:
1764088
37.

Distribution of angiotensin II receptor subtypes in rat brain nuclei.

Obermüller N, Unger T, Culman J, Gohlke P, de Gasparo M, Bottari SP.

Neurosci Lett. 1991 Oct 28;132(1):11-5.

PMID:
1787912
38.

Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins.

Bottari SP, Taylor V, King IN, Bogdal Y, Whitebread S, de Gasparo M.

Eur J Pharmacol. 1991 Jun 19;207(2):157-63.

PMID:
1908781
39.

Hormonal regulation myometrial adrenergic responses: the receptor and beyond.

Roberts JM, Riemer RK, Bottari SP, Wu YY, Goldfien A.

J Dev Physiol. 1989 Mar;11(3):125-34. Review.

PMID:
2553793
40.

Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.

Riemer RK, Wu YY, Bottari SP, Jacobs MM, Goldfien A, Roberts JM.

Mol Pharmacol. 1988 Apr;33(4):389-95.

PMID:
2833685
41.

Oxytocin and vasopressin: distinct receptors in myometrium.

Guillon G, Balestre MN, Roberts JM, Bottari SP.

J Clin Endocrinol Metab. 1987 Jun;64(6):1129-35.

PMID:
3033005
42.

Myometrial beta 1-adrenoreceptors are detectable only in the midfollicular phase.

Bottari SP, Severne Y, Kaivez E, Lescrainier JP, Roberts JM, Vauquelin GP.

J Clin Endocrinol Metab. 1986 Jun;62(6):1220-6.

PMID:
2871040
43.

Regulation of alpha- and beta-adrenergic receptor subclasses by gonadal steroids in human myometrium.

Bottari SP, Vokaer A, Kaivez E, Lescrainier JP, Vauquelin G.

Acta Physiol Hung. 1985;65(3):335-46.

PMID:
2990161
44.

Differential regulation of alpha-adrenergic receptor subclasses by gonadal steroids in human myometrium.

Bottari SP, Vokaer A, Kaivez E, Lescrainier JP, Vauquelin GP.

J Clin Endocrinol Metab. 1983 Nov;57(5):937-41.

PMID:
6311865
45.

Identification and characterization of alpha 2-adrenergic receptors in human myometrium by [3H]rauwolscine binding.

Bottari SP, Vokaer A, Kaivez E, Lescrainier JP, Vauquelin G.

Am J Obstet Gynecol. 1983 Jul 15;146(6):639-43.

PMID:
6135347
46.

Identification and characterization of alpha 1-adrenergic receptors in human myometrium by [3H]prazosin binding.

Bottari SP, Vauquelin G, Lescrainier JP, Kaivez E, Vokaer A.

Biochem Pharmacol. 1983 Mar 1;32(5):925-8. No abstract available.

PMID:
6301504

Supplemental Content

Loading ...
Support Center